International Stem Cell seeks FDA approval for Parkinson's disease cell therapy

02/18/2014 | San Diego Union-Tribune

International Stem Cell is preparing to file an FDA application to begin its stem cell therapy program for patients with Parkinson's disease. Company officials have met with the FDA to discuss preclinical testing. The treatment involves the use of progenitor cells that develop into neural cells and promote the production of dopamine.

View Full Article in:

San Diego Union-Tribune

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD